Key result
A noninvasive transthoracic accelerometer strongly correlated with invasive LV dP/dt(max) changes after dobutamine in normal and failing minipig hearts.
Why the study?
Does a noninvasive transthoracic accelerometer accurately measure LV contractility compared to invasive LV dP/dt in a minipig model of heart failure?
Does a noninvasive transthoracic accelerometer accurately measure LV contractility compared to invasive LV dP/dt in a minipig model of heart failure?
A novel noninvasive transthoracic accelerometer strongly correlates with invasive LV dP/dt for assessing myocardial contractility and contractile reserve in a minipig model of heart failure.
Answers are grounded in this paper and cite their sources.
May facilitate noninvasive contractility monitoring in preclinical HF; leaves open human validation and clinical adoption.
BACKGROUND: Invasively measured left ventricular (LV) dP/dt is the accepted standard for measuring acute and chronic directional changes in LV contractility. Recently, we developed a noninvasive force sensor based on an accelerometer positioned on the chest, which measures the vibrations generated by isovolumic myocardial contraction. The aim of this paper was to compare noninvasive (accelerometer) versus invasive (LV dP/dt) indices of myocardial contractility in a chronic minipig model of pacing-induced heart failure (HF). Comparative assessment was performed both at rest and following dobutamine infusion. METHODS: In adult male minipigs (n = 6), LV contractility was simultaneously assessed both invasively (LV dP/dt, Millar catheter) and noninvasively (accelerometer) at rest and following dobutamine (up to 7.5 mcg/kg/min), both before and after development of HF by pacing the LV at 180 beats/min for 3 weeks. RESULTS: Invasive and noninvasive assessments were obtained in 24 conditions (12 at rest and 12 after dobutamine infusion). Sensor-based cardiac force changes were significantly related to positive peak LV dP/dt(max) changes following dobutamine infusion both in normal (r = 0.88, P < 0.001) and failing heart (r = 0.89, P < 0.001). The force-frequency relation showed a tight correlation between invasive and noninvasive assessment (r = 0.68, P = 0.02). CONCLUSIONS: The force-frequency relation can be assessed noninvasively by a transthoracic sensor based on an accelerometer. The method can efficiently detect the development of resting dysfunction and the contractile reserve at different HF steps, with potential for wearable HF monitoring.
No takes yet. Share an insight, caveat, or question.
Gemignani et al. (2010) studied Chronic heart failure (n=6). Noninvasive force sensor (accelerometer) vs. Invasive LV dP/dt (Millar catheter) was evaluated on Correlation between noninvasive sensor-based cardiac force changes and invasive positive peak LV dP/dt(max) changes (r = 0.88 (normal), r = 0.89 (failing), p=<0.001). A noninvasive transthoracic accelerometer strongly correlated with invasive LV dP/dt(max) changes after dobutamine in normal and failing minipig hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: